Which medications in the drug class Antineoplastics, Anti-CD20 Monoclonal Antibodies are used in the treatment of Pediatric Nephrotic Syndrome?

Updated: Mar 04, 2020
  • Author: Jerome C Lane, MD; Chief Editor: Craig B Langman, MD  more...
  • Print

Antineoplastics, Anti-CD20 Monoclonal Antibodies

Rituximab (Rituxan, Rituximab-abbs, Truxima)

Rituximab is a chimeric, anti-CD20 antibody that results in depletion of B cells. Rituximab may be considered in children with SDNS or FRNS in whom other treatments have failed or those with cumulative toxicity of other steroid-sparing agents

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!